Gene · 4277
Papers3,381
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,381
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pediatric Brain Tumours: Lessons from the Immune Microenvironment. | Curr Oncol | 2023 | 37232837 | PubTator, text mining | PubMed |
| Pan-cancer analysis reveals the prognostic and immunotherapeutic value of cytoskeleton-associated protein 2-like. | Sci Rep | 2023 | 37225919 | PubTator, text mining | PubMed |
| Immunopathogenesis of viral infections in neurological autoimmune disease. | BMC Neurol | 2023 | 37221459 | PubTator, text mining | PubMed |
| Today's Kaposi sarcoma is not the same as it was 40 years ago, or is it? | J Med Virol | 2023 | 37212317 | PubTator, text mining | PubMed |
| Sequential therapy with supercharged NK cells with either chemotherapy drug cisplatin or anti-PD-1 antibody decreases the tumor size and significantly enhances the NK function in Hu-BLT mice. | Front Immunol | 2023 | 37197660 | PubTator, text mining | PubMed |
| The Function of NK Cells in Tumor Metastasis and NK Cell-Based Immunotherapy. | Cancers (Basel) | 2023 | 37190251 | PubTator, text mining | PubMed |
| Risk Effects of rs1799945 Polymorphism of the HFE Gene and Intergenic Interactions of GWAS-Significant Loci for Arterial Hypertension in the Caucasian Population of Central Russia. | Int J Mol Sci | 2023 | 37176017 | PubTator, text mining | PubMed |
| Cell Therapy as Target Therapy against Colon Cancer Stem Cells. | Int J Mol Sci | 2023 | 37175871 | PubTator, text mining | PubMed |
| Sex-Specific Features of the Correlation between GWAS-Noticeable Polymorphisms and Hypertension in Europeans of Russia. | Int J Mol Sci | 2023 | 37175507 | PubTator, text mining | PubMed |
| Abscopal Effect, Extracellular Vesicles and Their Immunotherapeutic Potential in Cancer Treatment. | Molecules | 2023 | 37175226 | PubTator, text mining | PubMed |
| Nitroglycerin: a comprehensive review in cancer therapy. | Cell Death Dis | 2023 | 37173331 | PubTator, text mining | PubMed |
| A chimeric antigen receptor uniquely recognizing MICA/B stress proteins provides an effective approach to target solid tumors. | Med | 2023 | 37172578 | PubTator, text mining | PubMed |
| Combinatorial immunotherapy with gemcitabine and ex vivo-expanded NK cells induces anti-tumor effects in pancreatic cancer. | Sci Rep | 2023 | 37169953 | PubTator, text mining | PubMed |
| Engaging natural killer cells for cancer therapy via NKG2D, CD16A and other receptors. | MAbs | 2023 | 37165468 | PubTator, text mining | PubMed |
| Targeting HSF1 for cancer treatment: mechanisms and inhibitor development. | Theranostics | 2023 | 37153737 | PubTator, text mining | PubMed |
| Effects of the interactions between platelets with other cells in tumor growth and progression. | Front Immunol | 2023 | 37153586 | PubTator, text mining | PubMed |
| Antitumor effects of NK cells expanded by activation pre‑processing of autologous feeder cells before irradiation in colorectal cancer. | Oncol Lett | 2023 | 37153058 | PubTator, text mining | PubMed |
| Combination therapy of DKK1 inhibition and NKG2D chimeric antigen receptor T cells for the treatment of gastric cancer. | Cancer Sci | 2023 | 37151176 | PubTator, text mining | PubMed |
| New cell sources for CAR-based immunotherapy. | Biomark Res | 2023 | 37147740 | PubTator, text mining | PubMed |
| Vγ9Vδ2 T-cell immunotherapy in blood cancers: ready for prime time? | Front Immunol | 2023 | 37143664 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4277/papers?page=20